Johnson and Johnson Stock Surges on Strong Earnings and Raised Guidance

# Johnson & Johnson Stock Analysis: Q1 Earnings Beat Expectations, Stock Trades at $227.79 | Market Update 2026 Discover the latest **Johnson & Johnson stock analysis** in this comprehensive market update. JNJ shares are currently trading at $227.79, following impressive **Q1 2026 earnings results** that surpassed Wall Street expectations. In this episode, we break down: ✅ **Strong Q1 Performance**: JNJ reported EPS of $2.70 vs. analyst estimates of $2.68, with revenue hitting $24.6B against projected $23.6B ✅ **Raised Guidance**: Management increased full-year 2026 EPS guidance to $11.45-$11.65, demonstrating confidence in operational strength ✅ **Analyst Outlook**: Consensus "Moderate Buy" rating from 27 firms with an average price target of $252.48 - representing 10%+ upside potential ✅ **Key Metrics**: 21.83% net profit margin, 32.60% ROE, and a defensive beta of 0.27 ✅ **Recent Upgrades**: HSBC raises target to $280, Wells Fargo to $263 with overweight rating Perfect for investors tracking **healthcare stocks**, **dividend aristocrats**, and **large-cap pharmaceutical investments**. Get the essential market intelligence you need to make informed investment decisions about one of the world's leading healthcare companies. Subscribe for daily stock analysis, earnings updates, and investment insights. *A Quiet Please Production | Visit quietplease.ai for more market analysis podcasts* --- **Keywords**: Johnson & Johnson stock, JNJ stock analysis, healthcare stocks 2026, pharmaceutical investments, dividend stocks, earnings beat, stock market analysis For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.